Skip to main content
Skip to content
Case File
d-18900House OversightOther

Ackrell Capital Report on Cannabis Debt Financing

The document is a generic industry analysis of cannabis financing without any specific allegations, names, transactions, or controversial actions involving powerful actors. It offers no actionable inv Direct lenders are filling a financing gap for cannabis companies due to lack of bank loans. Debt costs for cannabis firms are 200‑500 basis points higher than other sectors. Valuations in the cannab

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #024771
Pages
1
Persons
0
Integrity
No Hash Available

Summary

The document is a generic industry analysis of cannabis financing without any specific allegations, names, transactions, or controversial actions involving powerful actors. It offers no actionable inv Direct lenders are filling a financing gap for cannabis companies due to lack of bank loans. Debt costs for cannabis firms are 200‑500 basis points higher than other sectors. Valuations in the cannab

Tags

capital-marketscannabis-industryindustry-analysishouse-oversightdebt-financing

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
ACKRELL CAPITAL CHAPTER VI|_ Capital Markets for Cannabis Companies In addition, an increasing number of direct lenders are participating in the private debt markets for cannabis-related companies. These lenders represent an important capital source for the industry, as typical forms of debt capital, such as bank financing, remain unavailable to most companies. As in other industries, debt financing is typically available only to those companies having meaningful cash flow or tangible assets to secure the debt. While the number of lenders is increasing, there is still a relative scarcity of debt capital available to the cannabis industry, which can lead to a higher debt cost of capital of 200-500 basis points or more for cannabis-related companies, as compared to companies in other industries. The following chart illustrates the type of debt that may be available to cannabis-related companies, representative terms of such debt, and the types of companies that may be able to access debt in the private markets. Debt Financing Alternatives for Cannabis-Related Companies Cost of Capital Senior Low Double Digits Type of : Type of Securitization Borrowers: (if secured): \ Cultivators Lease Land ( Extractors Financing Buildings Dispensaries Mid-teens Equipment j Product Manufacturers AIR Inventory Convertible Debt Less Restrictive = Final Thoughts As stated previously, valuations and stock price fluctuations in the cannabis industry continue to be driven more by expectations for the cannabis industry in general than by individual company funda- mentals. Today, in the public markets, trading volumes are too low, trading prices are too volatile and operating histories are too limited to place any reliance on current valuation levels in the cannabis industry. We believe that this dynamic will continue until cannabis-related companies have matured and start to realize meaningful revenue, profitability and other financial metrics that will allow inves- tors to evaluate companies within the industry by more traditional methodology. It is still too early to know how the cannabis industry or its sectors will be valued in the future. It may come to pass that companies in the cannabis industry are valued comparably to public companies in industries with similar characteristics, such as the alcohol, tobacco, pharmaceutical and consumer © 2017 Ackrell Capital, LLC | Member FINRA/SIPC 135

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.